Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Hartford Financial Services Group | HIG | 5. nov 2024 | 111.63 | +0.42 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | 5. nov 2024 | 29.82 | +0.95 |
Harvard Bioscience | HBIO | 5. nov 2024 | 2.39 | +0.84 |
Hasbro | HAS | 5. nov 2024 | 66.96 | +1.36 |
Haverty Furniture Companies | HVT | 5. nov 2024 | 22.29 | +1.78 |
Haverty Furniture Companies | HVT-A | 5. nov 2024 | 22.42 | 0.00 |
Hawaiian Electric Industries | HE | 5. nov 2024 | 10.51 | +1.25 |
Hawkins | HWKN | 5. nov 2024 | 108.41 | +2.05 |
Hawthorn Bancshares | HWBK | 5. nov 2024 | 27.73 | +0.07 |
Haymaker Acquisition 4 | HYAC | 5. nov 2024 | 10.69 | -0.09 |
Haynes International | HAYN | 5. nov 2024 | 60.39 | -0.10 |
Hayward | HAYW | 5. nov 2024 | 16.28 | +0.56 |
HBT Financial | HBT | 5. nov 2024 | 21.52 | +2.48 |
HCA Healthcare | HCA | 5. nov 2024 | 366.66 | +0.96 |
HCI Group | HCI | 5. nov 2024 | 115.36 | +2.73 |
HCM II Acquisition | HOND | 5. nov 2024 | 9.98 | 0.00 |
HCM II Acquisition | HONDU | 5. nov 2024 | 10.05 | 0.00 |
HCW Biologics | HCWB | 5. nov 2024 | 0.43 | +0.23 |
HDFC Bank ADR | HDB | 5. nov 2024 | 64.24 | +2.77 |
Health Catalyst | HCAT | 5. nov 2024 | 7.76 | +1.04 |
Healthcare AI Acquisition A | HAIA | 5. nov 2024 | 11.46 | +0.35 |
Healthcare Alphadex First Trust | FXH | 5. nov 2024 | 109.43 | +1.22 |
Healthcare Bull 3X Direxion | CURE | 5. nov 2024 | 116.23 | +2.17 |
Healthcare ETF Vanguard | VHT | 5. nov 2024 | 272.60 | +0.85 |
Healthcare Realty Trust | HR | 5. nov 2024 | 17.57 | +2.03 |
Healthcare Select Sector SPDR | XLV | 5. nov 2024 | 147.85 | +0.74 |
Healthcare Services Group | HCSG | 5. nov 2024 | 11.39 | +1.97 |
Healthcare Triangle | HCTI | 5. nov 2024 | 1.31 | +2.34 |
HealthEquity | HQY | 5. nov 2024 | 89.23 | +2.62 |
Healthpeak Properties | DOC | 5. nov 2024 | 22.51 | +2.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.